Healthcare Antitrust: Heightened Enforcement by Federal and State Agencies
Recording of a 90-minute CLE video webinar with Q&A
This CLE course will guide healthcare counsel on recent antitrust developments and the implications for the healthcare industry. The panel will discuss healthcare antitrust enforcement priorities under the Biden Administration, changes at the federal antitrust enforcement agencies, state enforcement trends, and recent healthcare antitrust litigation.
Outline
- Biden administration antitrust enforcement priorities in healthcare
- Changes at the federal antitrust agencies
- State enforcement trends and regulatory changes
- Recent DOJ and FTC antitrust enforcement actions in the healthcare industry
Benefits
The panel will review these and other key issues:
- Changes to healthcare antitrust enforcement at the state and federal level
- Healthcare antitrust under the Biden administration
Faculty
Michael R. Greer
Shareholder
Hall Render Killian Heath & Lyman
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust... | Read More
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust practice, he has extensive experience in counseling health systems, hospitals and physicians on the antitrust requirements of mergers, acquisitions, joint ventures and provider networks. In this capacity, Mr. Greer frequently obtains clearance from the FTC and DOJ under the premerger reporting requirements of the Hart-Scott-Rodino (HSR) Act and defends providers in government antitrust investigations. During these government investigations, he manages complex procedural requirements, including large-scale document productions and electronic discovery and negotiates competition issues with the federal antitrust enforcement agencies. In addition, Mr. Greer routinely counsels healthcare providers on day-to-day antitrust compliance issues related to provider networks, managed care contracting, dominant firms and exchanges of competitively sensitive information, including “all or nothing” contracting, anti-tiering, anti-steering, gag clauses and price transparency. He also serves as part of an antitrust compliance monitoring team in monitoring antitrust agency consent orders.
Close
E. John Steren
Member
Epstein Becker & Green
Mr. Steren devotes a significant portion of his practice to helping healthcare organizations manage the antitrust risks... | Read More
Mr. Steren devotes a significant portion of his practice to helping healthcare organizations manage the antitrust risks of joint ventures and other business arrangements. He represents healthcare entities and providers in antitrust matters (counseling and litigation), including civil and government investigations and compliance with Hart-Scott-Rodino premerger notification requirements. He also focuses his practice on other complex commercial and civil litigation matters.
Close